Boryung Pharm successfully hold Dukarb’s 1st anniversary symposium

Published: 2017-09-12 13:46:48

Updated: 2017-09-12 13:46:48

Boryung Pharm(CEO Tae-Hong Choi) held a special symposium at Paradise City Hotel & Resort Incheon between the 9^th and 10^th to celebrate the Dukarb’s 1^st release anniversary. Dukarb is a Kanarb/amlodipine combination medicine for the treatment of hypertension.

At the symposium participated by about 200 medical specialists, Managing Director Hyung-Jin Jung at Boryung Pharm introduced Kanarb’s(ge...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.